Top

Pediatric Nephrology

Published in:

01-03-2021 | Leishmania | Clinical Quiz

A rare cause of postinfectious glomerulonephritis: Answers

Authors: Ozlem Yuksel Aksoy, Adem Yasin Koksoy, Saba Kiremitci, Nilgun Cakar, Fatma Semsa Cayci

Published in: Pediatric Nephrology | Issue 3/2021

Excerpt

Answers

Acute postinfectious glomerulonephritis associated with cutaneous leishmaniasis.

It is not recommended to continue steroids in such cases due to the risk of dissemination of cutaneous leishmaniasis. Steroid treatment of the patient was gradually tapered and stopped.

Intralesional glucantime (meglumine antimoniate) weekly with intravenous amphotericin B and cryotherapy were used in the treatment of the patient.

Besides postinfectious glomerulonephritis, the differential diagnosis of a case with hematuria and low C3 levels includes C3 glomerulonephritis and lupus nephritis; and in cases of hematuria with normal complement levels, IgA nephropathy must be kept in mind.

…

Dagan R, Cleper R, Davidovits M et al (2016) Post-infectious glomerulonephritis in pediatric patients over two decades: severity-associated features. Isr Med Assoc J 18(6):336–340PubMed

Hunt E, Somers M (2019) Infection-related glomerulonephritis. Pediatr Clin N Am 66(1):59–72. https://doi.org/10.1016/j.pcl.2018.08.005CrossRef

Ilyas M, Tolaymat A (2008) Changing epidemiology of acute post-streptococcal glomerulonephritis in northeast Florida: a comparative study. Pediatr Nephrol 23:1101–1106CrossRef

Becquet O, Pasche J, Gatti H et al (2010) Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study. Pediatr Nephrol 25(2):275–280CrossRef

Wong W, Lennon DR, Crone S et al (2013) Prospective population-based study on the burden of disease from post-streptococcal glomerulonephritis of hospitalised children in New Zealand: epidemiology, clinical features and complications. J Paediatr Child Health 49(10):850–855CrossRef

Brown DD, Reidy KJ (2019) Approach to the child with hematuria. Pediatr Clin N Am 66(1):15–30. https://doi.org/10.1016/j.pcl.2018.08.003CrossRef

Sethi S, Haas M, Markowitz GS et al (2016) Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol 27:1278–1287CrossRef

Sethi S, Fervenza FC, Siddiqui A, Quint PS, Pritt BS (2016) Leishmaniasis-associated membranoproliferative glomerulonephritis with massive complement deposition. Kidney Int Rep 1:125–130. https://doi.org/10.1016/j.ekir.2016.06.003CrossRefPubMedPubMedCentral

Pickering MC, D’Agati VD, Nester CM et al (2013) C3 glomerulopathy: consensus report. Kidney Int 84:1079–1089. https://doi.org/10.1038/ki.2013.377CrossRefPubMedPubMedCentral

10.

Ravindran A, Fervenza FC, Smith RJH, Vriese ASD, Sethi S (2020) C3 glomerulopathy: ten years’ experience at Mayo Clinic. Mayo Clinic Proceedings 93:991–1008. https://doi.org/10.1016/j.mayocp.2018.05.019CrossRef

11.

Sethi S, Fervenza FC, Zhang Y et al (2012) C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int 82:465–473. https://doi.org/10.1038/ki.2012.212CrossRefPubMedPubMedCentral

12.

De Vriese AS, Sethi S, Van Praet J, Nath KA, Fervenza FC (2015) Kidney disease caused by dysregulation of the complement alternative pathway: an etiologic approach. J Am Soc Nephrol 26:2917–2929. https://doi.org/10.1681/ASN.2015020184CrossRefPubMedPubMedCentral

13.

Angioi A, Fervenza FC, Sethi S et al (2016) Diagnosis of complement alternative pathway disorders. Kidney Int 89:278–288. https://doi.org/10.1016/j.kint.2015.12.003CrossRefPubMed

14.

Sethi S, Nester CM, Smith RJ (2012) Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 81:434–441CrossRef

15.

Servais A, Noël LH, Roumenina LT et al (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454–464CrossRef

16.

Riedl M, Thorner P, Licht C (2017) C3 glomerulopathy. Pediatr Nephrol 32:43–57. https://doi.org/10.1007/s00467-015-3310-4CrossRefPubMed

17.

Magill AJ (2009) Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 7th edn. Churchill Livingstone, London, pp 3463–3480

18.

Bezerra G, José E, Barros G, Francesco ED (2020) Review article kidney involvement in leishmaniasis — a review. Braz J Infect Dis 18:434–440. https://doi.org/10.1016/j.bjid.2013.11.013CrossRef

19.

Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz DN (2011) Renal involvement in leishmaniasis: a review of the literature. NDT Plus 4:147–152. https://doi.org/10.1093/ndtplus/sfr008CrossRefPubMedPubMedCentral

20.

Chappuis F, Sundar S, Hailu A et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873–882. https://doi.org/10.1038/nrmicro1748CrossRefPubMed

21.

Enríquez R, Sirvent AE, Padilla S, Toro P, Sánchez M, Millán I (2015) Am J Case Rep 16:8–11. https://doi.org/10.12659/AJCR.892641CrossRefPubMedPubMedCentral

22.

Salgado Filho N, Ferreira TM, Costa JM (2003) Involvement of the renal function in patients with visceral leishmaniasis (kala-azar). Rev Soc Bras Med Trop 36:217–221. https://doi.org/10.1590/s0037-86822003000200004CrossRefPubMed

23.

Lima Verde FA, Lima Verde FA, Lima Verde IA et al (2007) Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol 20:430–436PubMed

24.

Sartori A, De Oliveira AV, Roque-Barreira MC et al (1987) Immune complex glomerulonephritis in experimental kala-azar. Parasite Immunol 9:93–103CrossRef

25.

Balsan M, Fenech F (1992) Acute renal failure in visceral leishmaniasis treated with sodium stibogluconate. Trans R Soc Trop Med Hyg 86:515–516CrossRef

26.

Oliveira RA, Lima CG, Mota RM et al (2012) Renal function evaluation in patients with American cutaneous leishmaniasis after specific treatment with pentavalent antimonial. BMC Nephrol 13:44. https://doi.org/10.1186/1471-2369-13-44CrossRefPubMedPubMedCentral

27.

Oliveira RA, Diniz LFB, Teotonio LO et al (2011) Renal tubular dysfunction in patients with American cutaneous leishmaniasis. Kidney Int 80:1099–1106. https://doi.org/10.1038/ki.2011.251CrossRefPubMed

28.

Melby PC, Kreutzer RD, McMahon-Pratt D et al (1992) Cutaneous leishmaniasis: review of 59 cases seem at the National Institute of Health. Clin Infect Dis 15:924–937CrossRef

29.

Ortiz M, Mon C, Herrero JC et al (2015) Glomerulonephritis and cryoglobulinemia : first manifestation of visceral leishmaniasis. Clin Nephrol 83:370–377. https://doi.org/10.5414/CN108195CrossRefPubMed

30.

Tuon FF, Sabbaga Amato V, Floeter-Winter LM et al (2007) Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids – first report. Int J Dermatol 46:628–630. https://doi.org/10.1111/j.1365-4632.2006.03096.xCrossRefPubMed

Title: A rare cause of postinfectious glomerulonephritis: Answers
Authors: Ozlem Yuksel Aksoy
Adem Yasin Koksoy
Saba Kiremitci
Nilgun Cakar
Fatma Semsa Cayci
Publication date: 01-03-2021
Publisher: Springer Berlin Heidelberg
Keywords: Leishmania
Hematuria
Glomerulonephritis
Leishmania
Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
Visceral Leishmaniasis
Visceral Leishmaniasis
Visceral Leishmaniasis
Published in: Pediatric Nephrology / Issue 3/2021
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-020-04674-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A rare cause of postinfectious glomerulonephritis: Answers

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2021

The CKiD study: overview and summary of findings related to kidney disease progression

New therapeutic perspectives for IgA nephropathy in children

Treatment of IgA nephropathy in children: a land without KDIGO guidance

Recurrent urinary tract infection and nephrocalcinosis: Answers

A rare case of hyporeninemic hypertension: Questions

The old becomes new: advances in imaging techniques to assess nephron mass in children